50881-0006 ZYNYZ - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

50881-0006

Brand Name:

ZYNYZ

Generic Name:

Retifanlimab-dlwr

Dosage Form Name:

INJECTION

Administration Route:

Intravenous

Substances:

Name: RETIFANLIMAB

Strength: 25.0

Unit: mg/mL

Packages:

Code: 50881-0006-03

Description: 1 VIAL, SINGLE-USE in 1 CARTON (50881-006-03) / 20 mL in 1 VIAL, SINGLE-USE

Effective Date: March 22, 2023

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Checkpoint Inhibitor

Minor Class:

PD-1

Orphan Drug Designation:

Status:

In Use